| URL | https://investors.modernatx.com/news-releases/news |
| Source | Moderna press release |
| Date Published | 06/25/2020 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Moderna Therapeutics |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| City reshored to: | Cambridge |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | covid-19 vaccine |
| What domestic positive factors made reshoring more attractive? | , covid-19 |